Following successful clinical trials at Norwood Hospital under Dr. John Cadigan III, the FDA approved the breakthrough clot-dissolving heart attack drug TPA.
Following successful clinical trials at Norwood Hospital under Dr. John Cadigan III, the FDA approved the breakthrough clot-dissolving heart attack drug TPA.